Aclarion, Inc. (NASDAQ:ACONW) Sees Significant Growth in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totaling 4,580 shares, an increase of 87.3% from the June 15th total of 2,445 shares. Based on an average trading volume of 100,486 shares, the days-to-cover ratio is presently 0.0 days.

Aclarion Stock Performance

Shares of NASDAQ:ACONW traded up $0.00 during trading hours on Friday, hitting $0.02. 7,688 shares of the company’s stock traded hands, compared to its average volume of 20,338. Aclarion has a 52 week low of $0.02 and a 52 week high of $0.23. The company’s fifty day simple moving average is $0.03 and its two-hundred day simple moving average is $0.03.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.